Literature DB >> 3110834

Ontogeny of GABA-ergic and dopaminergic mediation of gnawing behavior in the mouse.

E Tirelli.   

Abstract

The ontogenetic course of dopaminergically mediated gnawing and the potentiation of this behavior by muscimol (a GABA receptor agonist) was explored in developing and young adult mice using a time-sampling (in 5-, 8-, 11-, and 14-day-old pups), or a corrugated paper procedure (in 14-, 17-, 20-, 23-, 26-, 35-, and 53-day-old animals). In experiment 1, the older mice group (14-53 days), displayed a dose-dependent gnawing behavior after methylphenidate, a dopamine indirect agonist (20, 30, 50 mg/kg). Similarly, in 5-, 8-, 11-, and 14-day-old pups, methylphenidate (10, 20, 50 mg/kg) evoked stereotyped gnawing (or indissociable gnawing-licking in 5-day-old pups), with maximal effects after the two lower doses at 8-11 days of age (experiment 2). Muscimol pretreatment (dosages ranging from 0.025 to 1.3 mg/kg) induced a clear-cut potentiation of gnawing elicited by methylphenidate (10 or 20 mg/kg) as early as 8 days of age (experiments 3 and 4). However, muscimol did not potentiate gnawing in 5-day-old pups treated with 10 or 2.5 mg/kg methylphenidate. The effectiveness of methylphenidate in inducing gnawing-licking among 5-day-old pups confirms the early maturation of central dopamine receptors reported in the literature. It is speculated that the absence of potentiating action of muscimol on methylphenidate-induced gnawing-licking at this age may be due to a functional immaturity of the GABAergic striato-nigro-tectal system, which is thought to transmit dopaminergic striatal stereotyped response at the output stations (recent review by Scheel-Krüger 1986).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3110834     DOI: 10.1007/bf00215485

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  35 in total

1.  Neurochemical aspects of the ontogenesis of GABAnergic neurons in the rat brain.

Authors:  J T Coyle; S J Enna
Journal:  Brain Res       Date:  1976-07-23       Impact factor: 3.252

2.  Postnatal changes in the high affinity uptake of glycine and GABA in the rat central nervous system.

Authors:  G A Johnston; L P Davies
Journal:  J Neurochem       Date:  1974-01       Impact factor: 5.372

3.  Ontogeny of behavioral development, arousal and stereotypes in two strains of mice.

Authors:  E Alleva; C Castellano; A Oliverio
Journal:  Exp Aging Res       Date:  1979-08       Impact factor: 1.645

4.  The development of responsiveness to dopaminergic agonists.

Authors:  D K Reinstein; D McClearn; R L Isaacson
Journal:  Brain Res       Date:  1978-07-07       Impact factor: 3.252

5.  Behavioral and biochemical analysis of GABA-mediated inhibition in the early chick embryo.

Authors:  J L Reitzel; J L Maderdrut; R W Oppenheim
Journal:  Brain Res       Date:  1979-08-31       Impact factor: 3.252

6.  Postnatal development of GABA binding sites and their endogenous inhibitors in rat brain.

Authors:  J H Skerritt; G A Johnston
Journal:  Dev Neurosci       Date:  1982 Mar-Jun       Impact factor: 2.984

7.  Psychopharmacological effects of low and high doses of apomorphine during ontogeny.

Authors:  I A Shalaby; L P Spear
Journal:  Eur J Pharmacol       Date:  1980-10-31       Impact factor: 4.432

8.  Nigral muscimol infusions facilitate the development of seizures in immature rats.

Authors:  S L Moshé; B J Albala
Journal:  Brain Res       Date:  1984-04       Impact factor: 3.252

9.  GABA, taurine and hypotaurine in developing mouse brain.

Authors:  P Kontro; K M Marnela; S S Oja
Journal:  Acta Physiol Scand Suppl       Date:  1984

10.  Behavioural stimulation induced by muscimol and other GABA agonists injected into the substantia nigra.

Authors:  J Scheel-Krüger; J Arnt; G Magelund
Journal:  Neurosci Lett       Date:  1977-05       Impact factor: 3.046

View more
  1 in total

1.  Ontogeny of muscimol effects on locomotor activity, habituation, and pain reactivity in mice.

Authors:  G Laviola; E Alleva
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.